In conversation with... Michael Pavlides

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.

Episode metadata supplied by the publisher feed · Published Jul 6, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Michael Pavlides

0:00 17:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 17 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on July 6, 2026.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!